Silvia Gasperoni - Concepedia

Author

Silvia Gasperoni

Azienda Ospedaliero-Universitaria Careggi

Also Known As

A M Frezza, S Gasperoni, S. Gasperoni, Silvia Gasperoni

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliero-Universitaria Careggi Fondazione IRCCS Istituto Nazionale dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico University of Bologna Candiolo Cancer Institute

About

Silvia Gasperoni is an author at Azienda Ospedaliero-Universitaria Careggi specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2.1K
2	Gastroenterology	6	6	667
3	Health Sciences	2	2	28
4	Microbiology	1	1	15
5	Orthopaedics	1	1	408

Silvia Gasperoni

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, Annals of Oncology Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology	2021	879
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Stefan Bielack, N. Abecassis, Annals of Oncology	2018	618
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Jean‐Yves Blay, N. Abecassis, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2021	509
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up Sandra J. Strauss, Anna Maria Frezza, N. Abecassis, Annals of Oncology Bone DiseaseBone SarcomasSurgical OncologyBone ImagingMedicine	2021	408
Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC Francesco Di Costanzo, Silvia Gasperoni, L. Manzione, JNCI Journal of the National Cancer Institute	2008	131
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) Francesco Di Costanzo, Paolo Carlini, Laura Doni, British Journal of Cancer	2005	98
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo, Annals of Oncology Surgical OncologyOncologyGastrointestinal OncologyMedicineFolinic Acid	2014	89
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma Giorgio Cocconi, Paolo Carlini, Alessandro Gamboni, Annals of Oncology OncologyMedicinePathologyAdvanced Gastric CarcinomaAnti-cancer Agent	2003	65

Page 1